Skip to main content
Home

Top menu InfoLep

  • About InfoLep


Main navigation

  • Home
  • Leprosy [5]
    • Global and Regional Leprosy Situation
    • WHO Global Leprosy Strategy
    • ILEP Strategy
    • World Leprosy Day
    • Leprosy journals
  • Key topics [7]
    • Leprosy and COVID-19
    • Diagnostic tests
    • Prevention of leprosy [2]
      • Interventions to reduce transmission: post-exposure prophylaxis (PEP) [3]
        • LPEP Programme
        • PEP++ project
        • PEP4LEP project
      • Interventions to reduce transmission: vaccines
    • Rehabilitation & prevention of disability [2]
      • Preventing leprosy-related disabilities in girls and boys
      • Self-care in leprosy
    • Antimicrobial resistance in leprosy
    • Stigma, discrimination & mental wellbeing [4]
      • World Leprosy Day 2022
      • Gender
      • Mental wellbeing
      • SARI Project
    • Bioarchaeology of leprosy
  • Toolkits [6]
    • Guides on Stigma and Mental Wellbeing [5]
      • Guide 1. What are health-related stigma and mental wellbeing? [8]
        • 1. What is stigma?
        • 2. Why does stigma exist?
        • 3. What are the causes of stigma?
        • 4. Who stigmatises?
        • 5. How does it feel to experience stigma?
        • 6. What are the effects of stigma?
        • 7. Effects of stigma and discrimination on mental wellbeing
        • Annex Guide 1
      • Guide 2. How to reduce the impact of stigma [7]
        • 1. From undetected disease to diagnosis to support
        • 2. Individual-level interventions
        • 3. Group-level interventions
        • 4. Family-level interventions
        • 5. Referral
        • 6. Further reading
        • Annexes Guide 2
      • Guide 3. How to reduce sources of stigma [6]
        • 1. Background to the design of a stigma-reduction intervention
        • 2. Identifying the sources of stigma
        • 3. Targeting an intervention
        • 4. Inclusion of affected persons and champions in interventions
        • 5. Interventions by source type
        • Annexes Guide 3
      • Guide 4. How to assess health-related stigma and mental wellbeing [9]
        • 1. What is the purpose of the assessment?
        • 2. What approach would best fit your purpose and context?
        • 3. Quantitative assessment methods
        • 4. Qualitative assessment methods
        • 5. Assessments using mixed methods
        • 6. Developing qualitative methods from scratch
        • 7. How do you conduct a stigma assessment?
        • 8. How to interpret and report your findings
        • Annexes Guide 4
      • Glossary
    • NTD Morbidity and Disability Toolkit [15]
      • CHIEF
      • Clinical Profile
      • EMIC affected persons
      • EMIC-CS Community Stigma
      • Participation Scale
      • Patient Health Questionnaire (PHQ-9)
      • 5-Question Stigma Indicators
      • Salsa Scale
      • SARI Stigma Scale
      • SDS Social Distance Scale
      • SRQ Self-reporting Questionnaire
      • Warwick-Edinburgh Mental Wellbeing Scale (WEMWBS)
      • WGQ Washington Group Questions
      • WHODAS
      • WHOQOL-BREF
    • Perception Study Toolkit (PST)
    • Zero Leprosy Toolkit
    • CBM's Community Mental Health Good Practice Guides
    • GPZL & Infolep Factsheets
  • Publications
  • Practical materials
  • Organizations

Top menu - mobile infoLep

  • About InfoLep

Refine your results

Refine your results


Selected filters

  • Reset filters
  • 1996
  • Leprosy (Hansen disease)
  • Clarithromycin - CLARI
  • Minocycline - MINO
  • Ofloxacin - OFLO

Filter by type

  • Publications

NTD

  • (-) Leprosy (Hansen disease) (1)

Subject

  • Immunoprophylaxis / Vaccine (2)
  • Tuberculosis (1)
  • Foot wear (1)
  • Diabetes (1)
  • (-) Clarithromycin - CLARI (1)
  • Nonhuman primates (1)
  • Terminology as subject (1)
  • Nerve function impairment (NFI) (2)
  • Foot-related problems (2)
  • Wound care (1)
  • Costs / Cost-effectiveness of interventions (1)
  • Delays in diagnosis (1)
  • Erythema nodosum leprosum - enl (Type 2 reaction) (3)
  • Eye-care (1)
  • Social Economic Rehabilitation (1)
  • (-) Minocycline - MINO (1)
  • Ridley-Jopling Scale (1)
  • (-) Ofloxacin - OFLO (4)
  • Nonhuman sources of leprosy (1)
  • Pregnancy (1)
  • Classification (3)
  • Rifampicin - RMP (2)
  • History of leprosy (3)
  • Complications and reactions (5)
  • Multi-drug therapy (MDT) (3)
  • Integrated approach (1)
  • Epidemiology (1)
  • Gender (5)
  • Prevention of disease (1)
  • Diagnosis (2)
  • Treatment (4)
  • Drug resistance (1)
  • Disability (1)
  • Prevention of disability (pod) (1)
  • Stigma (1)
  • Mental health (1)
  • Stigma (leprosy related) (2)

Resource type

  • Article (1)
  • Full text online (1)

Journal

  • Antimicrobial agents and chemotherapy (1)

Year of Publication

  • 2024 (0)
  • 2023 (3)
  • 2022 (0)
  • 2021 (0)
  • 2020 (0)
  • 2019 (0)
  • 2018 (0)
  • 2017 (0)
  • 2016 (0)
  • 2015 (0)
  • 2014 (0)
  • 2013 (0)
  • 2012 (0)
  • 2011 (1)
  • 2010 (0)
  • 2009 (0)
  • 2008 (0)
  • 2007 (0)
  • 2006 (1)
  • 2005 (0)
  • 2004 (0)
  • 2003 (1)
  • 2002 (0)
  • 2001 (1)
  • 2000 (2)
  • 1999 (0)
  • 1998 (0)
  • 1997 (1)
  • (-) 1996 (1)
  • 1995 (0)
  • 1994 (1)
  • 1993 (0)
  • 1992 (1)
  • 1991 (0)
  • 1990 (0)
  • 1989 (0)
  • 1988 (0)
  • 1987 (0)
  • 1986 (0)
  • 1985 (0)
  • 1984 (0)
  • 1983 (0)
  • 1982 (0)
  • 1981 (0)
  • 1980 (0)
  • 1979 (0)
  • 1978 (0)
  • 1977 (0)
  • 1976 (0)
  • 1975 (0)
  • 1974 (0)
  • 1973 (0)
  • 1972 (0)
  • 1971 (0)
  • 1970 (0)
  • 1969 (0)
  • 1968 (0)
  • 1967 (0)
  • 1966 (0)
  • 1965 (0)
  • 1964 (0)
  • 1963 (0)
  • 1962 (0)
  • 1961 (0)
  • 1960 (0)
  • 1959 (0)
  • 1958 (0)
  • 1957 (0)
  • 1956 (0)
  • 1955 (0)
  • 1954 (0)
  • 1953 (0)
  • 1952 (0)
  • 1951 (0)
  • 1950 (0)
  • 1949 (0)
  • 1948 (0)
  • 1947 (0)
  • 1946 (0)
  • 1945 (0)
  • 1944 (0)
  • 1942 (0)
  • 1941 (0)
  • 1940 (0)
  • 1939 (0)
  • 1938 (0)
  • 1937 (0)
  • 1936 (0)
  • 1935 (0)
  • 1934 (0)
  • 1933 (0)
  • 1932 (0)
  • 1931 (0)
  • 1930 (0)
  • 1929 (0)
  • 1928 (0)
  • 1927 (0)
  • 1926 (0)
  • 1925 (0)
  • 1924 (0)
  • 1923 (0)
  • 1922 (0)
  • 1921 (0)
  • 1920 (0)
  • 1919 (0)
  • 1917 (0)
  • 1916 (0)
  • 1915 (0)
  • 1914 (0)
  • 1913 (0)
  • 1912 (0)
  • 1911 (0)
  • 1910 (0)
  • 1909 (0)
  • 1908 (0)
  • 1907 (0)
  • 1906 (0)
  • 1905 (0)
  • 1904 (0)
  • 1903 (0)
  • 1902 (0)
  • 1901 (0)
  • 1899 (0)
  • 1898 (0)
  • 1897 (0)
  • 1896 (0)
  • 1895 (0)
  • 1893 (0)
  • 1892 (0)
  • 1891 (0)
  • 1890 (0)
  • 1889 (0)
  • 1888 (0)
  • 1886 (0)
  • 1883 (0)
  • 1881 (0)
  • 1880 (0)
  • 1879 (0)
  • 1878 (0)
  • 1877 (0)
  • 1876 (0)
  • 1875 (0)
  • 1874 (0)
  • 1873 (0)
  • 1872 (0)
  • 1870 (0)
  • 1868 (0)
  • 1867 (0)
  • 1866 (0)
  • 1864 (0)
  • 1863 (0)
  • 1861 (0)
  • 1857 (0)
  • 1855 (0)
  • 1847 (0)
  • 1800 (0)
  • 1765 (0)
  • 93 (0)
  • 2 (0)
  • 0 (0)

Language

  • English (1)

Regional focus

  • European Region (EUR) (1)
    • France (1)
 
  • Relevance
  • Date
1 items

Publication

Bactericidal activities of combinations of new drugs against Mycobacterium leprae in nude mice.

Ji B, Perani E G, Petinom C, et al. Antimicrobial agents and chemotherapy. 1996; 40 (2) : 393-9.
Download PDF

Use Ris for EndNote, Mendeley, RefWorks, Zotero and most other reference management software.

Quick links

  • Leprosy
  • Key topics
  • Toolbox
  • Publications
  • Organizations

Support

  • Contact
  • Privacy statement
  • Contact
  • FAQ

Contact us

info@infolep.org

(+31) 20 595 0500

     

Stay up to date with the latest publications and news related to leprosy.

Subscribe to newsletter

Related websites:

  • infontd

© 2023 InfoNTD